Page last updated: 2024-12-06
menfegol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
menfegol: vaginal contraceptive tablet containing 60 mg Menphegol; active ingedient is a surface active agent known as p-menthanylphenyl polyoxyethylene ether also called TS-88 or menphegal; structure in UD 25:18h [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 65408 |
| MeSH ID | M0093443 |
Synonyms (6)
| Synonym |
|---|
| ts 88 |
| menfegol |
| 2-[4-(2-methyl-5-propan-2-ylcyclohexyl)phenoxy]ethanol |
| 38193-77-0 |
| DTXSID00959120 |
| 2-{4-[2-methyl-5-(propan-2-yl)cyclohexyl]phenoxy}ethan-1-ol |
Research Excerpts
Overview
Menfegol is a spermicide with in vitro activity against human immunodeficiency virus (HIV)
| Excerpt | Reference | Relevance |
|---|---|---|
| "Menfegol is a spermicide with in vitro activity against human immunodeficiency virus (HIV). " | ( Frequent use of menfegol spermicidal vaginal foaming tablets associated with a high incidence of genital lesions. Belsey, E; Goeman, J; Karam, M; Laga, M; Lange, JM; Mboup, S; Ndoye, I; Perriëns, JH; Piot, P; Sakho, LM, 1995) | 2.08 |
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| " This study indicates that the regular and proper use of OVT-n or OVT-m tablets are comparable and are a safe means of birth control." | ( A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol-9 versus menfegol) in Thai women. Chompootaweep, S; Dusitsin, N, 1990) | 0.49 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (12)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 33.49
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (33.49) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 6 (42.86%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (57.14%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||